ArticleFuture oncology (London, England)2024

Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors.

Limei Min et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.